These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4719456)

  • 1. Hyperglycemic and insulogenic effects of intravenous glucagon at different blood glucose levels.
    Garcia MJ; Czerwinski C; De Santis R; Lan VV; Ramey E; Penhos JC
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):707-10. PubMed ID: 4719456
    [No Abstract]   [Full Text] [Related]  

  • 2. Exhaustion of blood glucose response and enhancement of insulin response after repeated glucagon injections in type-2 diabetes: potentiation by progressive hyperglycemia.
    Castillo MJ; Scheen AJ; Paolisso G; Lefebvre PJ
    Ann Endocrinol (Paris); 1996; 57(5):395-402. PubMed ID: 8991103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin response to glucagon in diabetic children.
    Weber B; Neumann B
    Z Kinderheilkd; 1973 Aug; 115(2):175-85. PubMed ID: 4790918
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin response to glucagon. The opposing effects of diabetes and obesity.
    Crockford PM; Hazzard WR; Williams RH
    Diabetes; 1969 Apr; 18(4):216-24. PubMed ID: 5776458
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of insulin secretion by glucagon and secretin.
    Deckert T
    Acta Endocrinol (Copenh); 1968 Apr; 57(4):578-84. PubMed ID: 5695271
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin, free fatty acids, and glucose response to intravenous glucagon following myocardial infarction.
    Gupta PR; Sinha MK; Dash RJ; Wahi PL; Rastogi GK
    Circulation; 1974 Feb; 49(2):357-60. PubMed ID: 4589699
    [No Abstract]   [Full Text] [Related]  

  • 8. Galanin inhibits insulin secretion and induces hyperglycemia in dogs.
    McDonald TJ; Dupre J; Tatemoto K; Greenberg GR; Radziuk J; Mutt V
    Diabetes; 1985 Feb; 34(2):192-6. PubMed ID: 2578419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of glucagon on insulin secretion. 1. A clinical study].
    Kuroda K
    Nihon Naibunpi Gakkai Zasshi; 1973 Dec; 49(12):1407-17. PubMed ID: 4798030
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of the intestinal polypeptides, IRP, GIP, VIP and motilin on insulin release in the rat.
    Turner DS; Etheridge L; Marks V; Brown JC; Mutt V
    Diabetologia; 1974 Oct; 10(5):459-63. PubMed ID: 4452430
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
    Goodner CJ; Conway MJ; Werbach JH
    J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose tolerance and insulin secretion in rabbits and dogs after ligation of the pancreatic ducts.
    Heptner W; Neubauer HP; Schleyerbach R
    Diabetologia; 1974 Jun; 10(3):193-6. PubMed ID: 4602674
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic compartmentalization of insulin. Evidence for pituitary control.
    Merimee TJ; Fineberg SE
    Diabetes; 1973 Jan; 22(1):25-9. PubMed ID: 4683793
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of glucagon on amino acid and nitrogen metabolism in fasting man.
    Aoki TT; Müller WA; Brennan MF; Cahill GF
    Metabolism; 1974 Sep; 23(9):805-14. PubMed ID: 4851644
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucagon mediated insulin release in man].
    Marks V; Salmols E
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():285-308. PubMed ID: 4907221
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous glucose tolerance and early insulin response. Studies on a random sample of women aged 50 and patients with diabetes mellitus.
    Blohmé G
    Acta Med Scand Suppl; 1974; 566():1-121. PubMed ID: 4533586
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of glucagon and insulin upon biliary lipid secretion.
    Meyers WC; Jones RS
    Am J Surg; 1979 Jan; 137(1):7-12. PubMed ID: 758844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.